Kyverna Therapeutics

Metallic arrow symbols illuminated by blue and magenta lights forming a graph on blue and magenta background
Biotech

Kyverna links CAR-T to autoimmune improvements in small trial

Kyverna saw deep, sustained improvements in autoimmune disease patients who received a single dose of its CAR T-cell therapy KYV-101.
Nick Paul Taylor Oct 29, 2025 10:00am
layoffs cuts workforce reduction chairs boxes fired

Kyverna lays off 16% as autoimmune CAR-T plans take shape

May 14, 2025 6:30am
photo of a paraglider in the foreground with the alps in the background

Flagship vet plants CEO roots at Pharming—Chutes & Ladders

Jan 24, 2025 8:30am
Warren Biddle

JPM25: Kyverna CEO sets priorities for CAR-T autoimmune biotech

Jan 13, 2025 7:30am
visual of a parachute

AI firm Xaira powers up C-suite with pharma vet—Chutes & Ladders

Dec 13, 2024 8:30am
Professional kite surfer soars through the air

2 Kite vets fly over to Kyverna Therapeutics—Chutes & Ladders

Sep 20, 2024 8:30am